We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

98 hedge funds and large institutions have $167M invested in Five Prime Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more capital invested

Capital invested by funds: $57.9M → $167M (+$109M)

165% more call options, than puts

Call options by funds: $567K | Put options by funds: $214K

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

13% more funds holding

Funds holding: 8798 (+11)

9% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 33

Holders
98
Holders Change
+11
Holders Change %
+12.64%
% of All Funds
2.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
30
Reduced
33
Closed
10
Calls
$567K
Puts
$214K
Net Calls
+$353K
Net Calls Change
+$1.2M
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$225K +$73.2K +17,767 +93%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$220K
Hudson Bay Capital Management
53
Hudson Bay Capital Management
Connecticut
$213K -$433K -105,000 -75%
AC
54
Athanor Capital
New York
$207K +$140K +33,943 New
AG
55
Algert Global
California
$186K -$27.9K -6,770 -18%
LPL Financial
56
LPL Financial
California
$171K +$115K +28,000 New
Jane Street
57
Jane Street
New York
$161K +$109K +26,468 New
Tudor Investment Corp
58
Tudor Investment Corp
Connecticut
$149K -$152K -36,794 -60%
Morgan Stanley
59
Morgan Stanley
New York
$139K -$154K -37,437 -62%
Bank of America
60
Bank of America
North Carolina
$128K +$13.5K +3,274 +19%
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$118K -$30.3K -7,344 -29%
Ohio Public Employees Retirement System (OPERS)
62
Ohio Public Employees Retirement System (OPERS)
Ohio
$118K +$79.7K +19,344 New
Squarepoint
63
Squarepoint
New York
$117K -$38.8K -9,412 -33%
Barclays
64
Barclays
United Kingdom
$117K -$10.8K -2,616 -12%
BFM
65
Boothbay Fund Management
New York
$116K +$3.73K +905 +5%
State of Wisconsin Investment Board
66
State of Wisconsin Investment Board
Wisconsin
$109K +$73.7K +17,900 New
HF
67
HRT Financial
New York
$107K +$72.5K +17,610 New
State Board of Administration of Florida Retirement System
68
State Board of Administration of Florida Retirement System
Florida
$104K
AIG
69
American International Group
New York
$100K -$15.7K -3,810 -19%
VF
70
Virtu Financial
New York
$91K +$61.5K +14,924 New
Connor, Clark & Lunn Investment Management (CC&L)
71
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$85K -$17.3K -4,209 -23%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$78K -$63K -15,300 -54%
UCFA
73
United Capital Financial Advisors
Texas
$77K
Deutsche Bank
74
Deutsche Bank
Germany
$75K +$6.32K +1,533 +14%
PVI
75
Pura Vida Investments
New York
$68K +$45.7K +11,100 New

FPRX Hedge Fund Activity: Q2 2020 in Review

98 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2020, worth a combined $167M — up 188% from $57.9M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FPRX positions and 10 closed out — a net gain of 12 holders — while 30 added to existing stakes and 33 trimmed.

The largest buyer was Candriam SCA, adding an estimated $2.07M. The largest seller was BlackRock, cutting an estimated $1.49M.

  • 98 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2020, up from 87 in Q1 2020.
  • Funds reported $167M of Five Prime Therapeutics, Inc. stock for Q2 2020, up 188% quarter-over-quarter.
  • 22 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2020 and 10 closed out, a net change of +12 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q2 2020 was Candriam SCA, an estimated $2.07M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q2 2020 was BlackRock, an estimated $1.49M sold.

Based on aggregated 13F filings for Q2 2020.